PERFORM FIRST AID FOR NERVE AGENT INJURY 1.

Slides:



Advertisements
Similar presentations
Emergency Management of Nerve Agent Casualties
Advertisements

Use of Auto-Injectors by Civilian Emergency Medical Personnel to Treat Civilians Exposed to Nerve Agent © © 1997 Lockheed Martin Energy Research Corporation.
Omaha Metropolitan Medical Response System OMMRS Administration of Mark I™ Kit, DuoDote™ and AtroPen® Auto-Injectors Presented by the OMMRS Pharmacy.
Viewgraph 1 Nerve Agent Antidote Kit, MARK I. Viewgraph 2 Holding MARK I (NAAK)
Product Name: DuoDote™ Auto-Injector1 Mark I™ Kit 2,3
National Urban Search & Rescue Response System National Urban Search & Rescue Response System Operation in the Contaminated Environment Version 4 National.
USAMRICD PROTECT, PROJECT, SUSTAIN U.S. ARMY MEDICAL RESEARCH INSTITUTE OF CHEMICAL DEFENSE TRIAGE CASE STUDIES MEDICAL MANAGEMENT OF CHEMICAL CASUALTIES.
Standardized Awareness Authorized Training, Train-the-Trainer Chemical Agents.
TSP 081-T PERFORM FIRST AID FOR HEAT INJURIES.
Pesticides and Human Health Chapter 6 Pesticide Applicator Core Training Manual.

Required when distributed (EMR, EMT, AEMT). Objectives At the completion of this education module, the provider will have: An understanding of scene safety.
Evaluate a Casualty Task #
Triage Tag Construction n Synthetic paper – Water resistant n 100 % resistant to all commonly used decontamination solutions – May be worn while patient.
Combat Life Saver LESSON 13 ADMINISTER FIRST AID TO A NERVE AGENT CASUALTY Compiled and edited by, 2LT John C. Miller, PA-C.
Nerve Agent Antidote Kit Training Objectives:
Nerve Agents: Recognition and Treatment Ventura County Emergency Medical Services.
Maryland State MARK I Training Program Nerve Agents and the MARK I Kits.
Copyright (c) The McGraw-Hill Companies, Inc. Permission required for reproduction or display Chapter 11 Emergency Medications.
1 Module 4 Signs and Symptoms. 2 Situation Assessment Known information regarding the chemical release Recognition of the event based on signs and symptoms.
Nerve Agent Antidote Kit
ATROPINE ONLY Initial, on scene, treatment by EMS for Nerve Agent or Organophosphate poisoning in the absence of Mark 1 kits.
So you think you might try using Drugs?. Drug Use Early on and Later.
Module 7 Medical Treatment
CHEMICAL TERRORISM This chemical terrorism case and discussion will focus on Nerve Agent exposure and toxicity.
Chemical Weapons Bolechová, Havelková. Types of Chemical Weapons Nerve Agents Blister Agents Blood Agents Choking Agents Incapacitating Agents.
Signs and Symptoms. Do you have or have you ever had __________? (Related to GI) abdominal distention abdominal pain abdominal rigidity bad breath belching.
Evaluate a Casualty STP 21-1-SMCT AUG 2003 FM
FCDPH ANAPHYLAXIS. Anaphylaxis (pronounced ana-fill-axis) is a serious allergic reaction that is rapid in onset and may cause death. FCDPH Retrieved from:
Perform First Aid for Heat Injuries
South Bay Disaster Resource Center at Harbor-UCLA Medical Center Nerve Agents & MARK 1 Antidote Administration.
CCBRN IDENTIFYING AND DEALING WITH CCBRN INCIDENTS.
Anaphylaxis Caring for Children in a Community Program
Heart Attack & Stroke. Heart Attack Myocardial Infarction: Death (necrosis) of a portion of the heart muscle caused by coronary artery obstruction causing.
WMD Operations Unit 5 slide 1 MODULE 2 UNIT 5 Chemical Agents.
Viewgraph 1 Signs and Symptoms of Heat Cramps Muscle cramps of an extremity and/or abdomen.
Section 5. Children with Special Health Care Needs.
© 1999 Lockheed Martin Energy Research Corporation CA128 NERVE AGENT EXPOSURE.
CHEMICAL AND BIOLOGICAL DEFENSE.
Sarin Serene Selli & Hannah Pritchard 7 th Period.
1 Click here to continue 2 Directions: This is a self-paced course on the use of a MK1 Kit after exposure to GB nerve agent. Proceed through the course.
Jessica Brooks Per. 8. Used to Treat Fever Pain ( headache, toothache, arthritis,cold and flu, migraine or menstrual cramps )
Nerve Agents.
Bioterrorism Drill Case 2 Nerve Agent: Patient Roles.
Omaha Metropolitan Medical Response System OMMRS Mark I Kit Training for Health Care Professionals © Presented by the OMMRS Pharmacy Subcommittee.
Response to Terrorism and Weapons of Mass Destruction Chapter 38.
Common Illnesses & Symptoms
Chapter 15. Common Sudden Illnesses  Fainting.  Diabetic emergencies.  Seizures.  Stroke.  Poisoning.  Heart attack.  Shock.
POISONS. TOXINS Poisons produced naturally by organisms Can cause: nausea, vomiting, paralysis, convulsions, death.
POISONS POISONS 1 § § POISONSCONTROL. CENTER NUMBER POISONS CONTROL. CENTER NUMBER 2.
H20: Hydration and You. 2/3 Of your body is made of water.
Sudden Illness PERIOD 5- MR. HAMILL. WHAT TO LOOK FOR ▪ Changes in level of consciousness ▪ Breathing Problems ▪ Signals of heart attack i.e. chest pain,
August 2005 EMS & Trauma Systems Section Office of Public Health Preparedness CHEMICAL AGENTS.
NERVE AGENTS. DEFINITION  A substance that causes biological effects by inhibiting acetylcholinesterase  Acetylcholine accumulates  Effects are due.
CHEMICAL AGENTS August 2005 EMS & Trauma Systems Section
Protecting those who protect us
How to treat organophosphate poisoning (Nerve agent/insecticide)
Use of Auto-Injectors by Civilian Emergency Medical Personnel to Treat Civilians Exposed to Nerve Agent© © 1997 Lockheed Martin Energy Research Corporation.
Perform First Aid for Heat Injuries
MEDICAL MANAGEMENT OF CHEMICAL CASUALTIES
Use of Auto-Injectors by Civilian Emergency Medical Personnel to Treat Civilians Exposed to Nerve Agent© OEMS Approval # for 2007:  (2 hours)
NERVE AGENT EXPOSURE CA128.
Evaluate A Casualty Task #
INFANT ILLNESS: SIGNS & SYMPTOMS
Evaluate A Casualty Task #
Poisons.
Lesson 22 ADMINISTER FIRST AID TO CHEMICAL AGENT CASUALTIES
LESSON 13 ADMINISTER FIRST AID TO A NERVE AGENT CASUALTY
Nerve Agent Antidote Kit, MARK I
State of Mississippi CHEMPACK Training Program
Presentation transcript:

PERFORM FIRST AID FOR NERVE AGENT INJURY 1

MILD SIGNS AND SYMPTOMS Unexplained runny nose Unexplained sudden headache Sudden drooling Tightness of the chest or difficulty breathing Difficulty seeing (dimness of vision and contraction of the pupils [miosis]) Localized sweating and muscular twitching in the area of exposed or contaminated skin Stomach cramps Nausea 1

NERVE AGENT ANTIDOTE KIT MARK I 2

HOLDING SET OF AUTOINJECTORS 2 PAM Cl ATROPINE Atropine 5

INTRAMUSCULAR INJECTION SITE ON THE LATERAL THIGH 3

INTRAMUSCULAR INJECTION SITE ON THE BUTTOCKS 4

GRASPING THE ATROPINE AUTOINJECTOR 6

REMOVING THE ATROPINE AUTOINJECTOR 7

GIVING INJECTION THIGH BUTTOCK

USED ATROPINE AUTOINJECTOR 10

REMOVING 2 PAM CL AUTOINJECTOR B 11

SECURED AUTOINJECTORS 12

ATNAA

PREPARING ATNAA FOR INJECTION

GIVING INJECTION THIGH BUTTOCK

SECURED ATNAA AUTOINJECTOR

SEVERE SIGNS AND SYMPTOMS Strange or confused behavior Wheezing, increased difficulty breathing (dyspnea), and coughing Severely pinpointed pupils Red eyes with tearing Vomiting Severe muscular twitching and general weakness Involuntary urination and defecation Convulsions Unconsciousness or stoppage of breathing 1

NERVE AGENT ANTIDOTE KIT MARK I 2

INJECTING CASUALTY’S THIGH

INJECTING CASUALTY’S BUTTOCK 18

CANA AUTOINJECTOR 21

USED MARK I & CANA AUTOINJECTORS 22

ATNAA

PREPARING ATNAA FOR INJECTION

CANA AUTOINJECTOR 21

USED ATNAA & CANA AUTOINJECTORS